$REGN Headlines Cal-Maine Foods shares fall on
Post# of 102855
Posted On: 01/05/2015 12:07:55 PM
$REGN Headlines
Cal-Maine Foods shares fall on earnings miss 4:41 p.m. Dec. 23, 2014 - Wallace Witkowski
Regeneron skids on shortfall in Eylea sales 11:15 a.m. Nov. 4, 2014 - Russ Britt
Regeneron Pharmaceuticals shares rise 8% 8:31 a.m. Oct. 17, 2014 - Sue Chang
10 rock-solid stocks for conservative investors 8:51 a.m. Sept. 17, 2014 - Philip van Doorn
S&P 500 nails the breakout point 9:35 a.m. Sept. 8, 2014 - Michael Ashbaugh
Regeneron shares run up 4.8% to lead S&P 500 gainers 8:34 a.m. Sept. 2, 2014 - Tomi Kilgore
Small health companies see large gains on a big earnings day 4:34 p.m. July 30, 2014 - Russ Britt
Twitter, U.S. Steel soar; Buffalo Wild Wings are burned 3:26 p.m. July 30, 2014 - Sue Chang
Edwards, Hospira rise as health-care companies see strong earnings 12:08 p.m. July 30, 2014 - Russ Britt
Regeneron shares jump after cholesterol drug meets test goals 10:16 a.m. July 30, 2014 - Russ Britt
Regeneron Pharmaceuticals jumps 7.7% 8:32 a.m. July 30, 2014 - Sue Chang
Dow ends at record high close but still shy of 17,000: Stock market live blog recap 3:04 p.m. July 1, 2014 - blogs.marketwatch.com
Twitter gains on new CFO; GM sales up in June 1:29 p.m. July 1, 2014 - Sue Chang
Oracle slides on disappointing results; CarMax soars 3:17 p.m. June 20, 2014 - Sue Chang
Maybe Amazon will unveil a toaster today 7:08 a.m. June 18, 2014 - Marek Fuchs
Twitter rallies ahead of earnings; 3D Systems retreats 2:49 p.m. April 29, 2014 - Sue Chang
Intuitive Surgical slumps; Facebook extends rally 2:41 p.m. April 9, 2014 - Sue Chang
44 stocks on takeover target radar: Morgan Stanley 11:48 a.m. March 25, 2014 - blogs.marketwatch.com
First Solar, H-P, Symantec are stocks to watch 3:16 p.m. March 21, 2014 - Sue Chang
First Solar extends winning streak; Symantec plunges 2:07 p.m. March 21, 2014 - Sue Chang
Jim Cramer: Isis Pharmaceuticals Gets a 'Gigantic' Boost With J&J Deal 14 min ago - TheStreet.com
Cramer Says Wells Fargo Is a Buy; Wait for a Regeneron Pullback 46 min ago - TheStreet.com
Insider Buying Still Strong During Year-End Holiday Week 8:29 a.m. Jan. 3, 2015 - 247WallSt.com
Biggest Movers in Healthcare Stocks Now – QGEN BABY ISRG REGN 12:45 p.m. Dec. 31, 2014 - InvestorPlace.com
Jim Cramer's 'Mad Money' Recap: How to Become an Even Better Investor 7:00 p.m. Dec. 30, 2014 - TheStreet.com
Portfolio Changes For The Fourth Quarter Of 2014 1:35 p.m. Dec. 30, 2014 - Seeking Alpha
InsiderInsights.com Daily Round Up 12/29/14: REGN, VRML, OAS, PTBI 1:23 p.m. Dec. 30, 2014 - Seeking Alpha
Esperion Therapeutics: ETC-1002 Is Appealing, But The Valuation Is Not 7:22 a.m. Dec. 30, 2014 - Seeking Alpha
DoctoRx Positions For 2015: I Have Cut Back On My Exposure To All Biotech Substantially 7:05 a.m. Dec. 30, 2014 - Seeking Alpha
Stock Market News for December 26, 2014 - Market News 10:10 a.m. Dec. 26, 2014 - Zacks.com
Why I Expect The Biotech Sell-Off To Continue Into 2015 8:08 a.m. Dec. 24, 2014 - Seeking Alpha
Regeneron's Valuation Has Moved Ahead Of Its Growth Potential 7:27 a.m. Dec. 24, 2014 - Seeking Alpha
Dow Reaches Record Close as Santa Claus Rally Hits Day 5 4:04 p.m. Dec. 23, 2014 - TheStreet.com
Dow, S&P 500 Near Session Highs After GDP Growth Smashes Expectations 2:25 p.m. Dec. 23, 2014 - TheStreet.com
Dow Industrials Top 18,000 but Biopharma Stocks Drag Nasdaq Lower 11:29 a.m. Dec. 23, 2014 - TheStreet.com
RBC’s 5 Top Biotech Stocks to Buy for 2015 9:07 a.m. Dec. 23, 2014 - 247WallSt.com
Making Money With Charles Payne: 12/22/14 6:00 p.m. Dec. 22, 2014 - FOXBusiness
Jim Cramer Answers Twitter (TWTR) Questions on Gilead, WhiteWave Foods, and More 1:37 p.m. Dec. 22, 2014 - TheStreet.com
Trade of the Day: IBB Up 40% YTD – Buy, Sell or Hold? 7:17 p.m. Dec. 21, 2014 - InvestorPlace.com
Seeking Alpha's Biotech Weekly: A Merck Purchase, Spectacular Auspex, And More 4:00 p.m. Dec. 19, 2014 - Seeking Alpha
Critical Alerts For iRobot, Regeneron Pharmaceuticals, Sears Holdings, Starbucks and Goldcorp Released By InvestorsObserver 9:31 a.m. Jan. 2, 2015 - PR Newswire - PRF
Regeneron Announces Presentation and Panel Discussion at the 33rd Annual J.P. Morgan Healthcare Conference 9:30 a.m. Dec. 19, 2014 - PR Newswire - PRF
Have You Been Counted? Regeneron and Sanofi US Join Forces with Leading Cardiovascular Organizations to Raise Awareness of Cholesterol 8:00 a.m. Dec. 15, 2014 - PR Newswire - PRF
Ablexis Announces Availability of the AlivaMab Mouse Technology and Settlement of the Litigation with Regeneron Pharmaceuticals, Inc. 8:01 a.m. Dec. 4, 2014 - BusinessWire - BZX
EYLEA® (aflibercept) Injection Accepted for Priority Review by FDA for Diabetic Retinopathy in Patients with Diabetic Macular Edema 7:00 a.m. Dec. 1, 2014 - PR Newswire - PRF
Critical Alerts For Qihoo 360 Technology, Regeneron Pharmaceuticals, Autodesk, Akamai Technologies and General Motors Released By InvestorsObserver 9:31 a.m. Nov. 26, 2014 - PR Newswire - PRF
Biotech Stocks in Motion - Amgen, Merrimack Pharma, NPS Pharma, BioMarin Pharma, and Regeneron Pharma 8:45 a.m. Nov. 24, 2014 - PR Newswire - PRF
Regeneron and Sanofi Announce that Dupilumab Has Received FDA Breakthrough Therapy Designation in Atopic Dermatitis 1:30 a.m. Nov. 20, 2014 - PR Newswire - PRF
Regeneron and Sanofi Announce New Results from Six Phase 3 Trials Showing that Alirocumab Significantly Reduced LDL Cholesterol 8:15 a.m. Nov. 19, 2014 - PR Newswire - PRF
Regeneron Announces EYLEA® (aflibercept) Injection Approved for the Treatment of Diabetic Macular Edema (DME) in Japan 3:05 a.m. Nov. 18, 2014 - PR Newswire - PRF
Regeneron and Sanofi Announce Positive Results from Phase 2b Study of Dupilumab in Patients with Moderate-to-Severe Asthma 1:00 a.m. Nov. 11, 2014 - PR Newswire - PRF
Regeneron Reports Third Quarter 2014 Financial and Operating Results 6:30 a.m. Nov. 4, 2014 - PR Newswire - PRF
Regeneron Announces Upcoming 2014 Investor Conference Presentations 4:01 p.m. Nov. 3, 2014 - PR Newswire - PRF
Upcoming Earnings, Financial Results, New Affiliations, and Study Results - Research Reports on Regeneron, Valeant, CVS Health, CIGNA and Baxter 9:15 a.m. Nov. 3, 2014 - PR Newswire - PRF
New Solution for Patients, Quarterly Financial Results, Clinical Study Initiation, Merger Updates, and Product Launch - Research Reports on CVS, Valeant, Regeneron, Allergan and Agilent 9:20 a.m. Oct. 23, 2014 - PR Newswire - PRF
Analyst Scanner on Biotech Equities - Amgen, Exelixis, Regeneron Pharma, Lexicon Pharma, and BioMarin Pharma 9:00 a.m. Oct. 20, 2014 - PR Newswire - PRF
Regeneron and Sanofi Announce Start of Phase 3 Study of Dupilumab in Patients with Atopic Dermatitis 7:00 a.m. Oct. 20, 2014 - PR Newswire - PRF
EYLEA® (aflibercept) Injection Demonstrates Significantly Greater Gains in Visual Acuity than Both Bevacizumab and Ranibizumab in NIH-Sponsored Diabetic Macular Edema Study 7:00 a.m. Oct. 17, 2014 - PR Newswire - PRF
Regeneron Ranked Number One Biopharmaceutical Employer by Science Magazine for Third Consecutive Year 2:00 p.m. Oct. 16, 2014 - PR Newswire - PRF
Regeneron Genetics Center Fully Operational, Announces New Collaborations and Key Appointments 8:30 a.m. Oct. 16, 2014 - PR Newswire - PRF
Cal-Maine Foods shares fall on earnings miss 4:41 p.m. Dec. 23, 2014 - Wallace Witkowski
Regeneron skids on shortfall in Eylea sales 11:15 a.m. Nov. 4, 2014 - Russ Britt
Regeneron Pharmaceuticals shares rise 8% 8:31 a.m. Oct. 17, 2014 - Sue Chang
10 rock-solid stocks for conservative investors 8:51 a.m. Sept. 17, 2014 - Philip van Doorn
S&P 500 nails the breakout point 9:35 a.m. Sept. 8, 2014 - Michael Ashbaugh
Regeneron shares run up 4.8% to lead S&P 500 gainers 8:34 a.m. Sept. 2, 2014 - Tomi Kilgore
Small health companies see large gains on a big earnings day 4:34 p.m. July 30, 2014 - Russ Britt
Twitter, U.S. Steel soar; Buffalo Wild Wings are burned 3:26 p.m. July 30, 2014 - Sue Chang
Edwards, Hospira rise as health-care companies see strong earnings 12:08 p.m. July 30, 2014 - Russ Britt
Regeneron shares jump after cholesterol drug meets test goals 10:16 a.m. July 30, 2014 - Russ Britt
Regeneron Pharmaceuticals jumps 7.7% 8:32 a.m. July 30, 2014 - Sue Chang
Dow ends at record high close but still shy of 17,000: Stock market live blog recap 3:04 p.m. July 1, 2014 - blogs.marketwatch.com
Twitter gains on new CFO; GM sales up in June 1:29 p.m. July 1, 2014 - Sue Chang
Oracle slides on disappointing results; CarMax soars 3:17 p.m. June 20, 2014 - Sue Chang
Maybe Amazon will unveil a toaster today 7:08 a.m. June 18, 2014 - Marek Fuchs
Twitter rallies ahead of earnings; 3D Systems retreats 2:49 p.m. April 29, 2014 - Sue Chang
Intuitive Surgical slumps; Facebook extends rally 2:41 p.m. April 9, 2014 - Sue Chang
44 stocks on takeover target radar: Morgan Stanley 11:48 a.m. March 25, 2014 - blogs.marketwatch.com
First Solar, H-P, Symantec are stocks to watch 3:16 p.m. March 21, 2014 - Sue Chang
First Solar extends winning streak; Symantec plunges 2:07 p.m. March 21, 2014 - Sue Chang
Jim Cramer: Isis Pharmaceuticals Gets a 'Gigantic' Boost With J&J Deal 14 min ago - TheStreet.com
Cramer Says Wells Fargo Is a Buy; Wait for a Regeneron Pullback 46 min ago - TheStreet.com
Insider Buying Still Strong During Year-End Holiday Week 8:29 a.m. Jan. 3, 2015 - 247WallSt.com
Biggest Movers in Healthcare Stocks Now – QGEN BABY ISRG REGN 12:45 p.m. Dec. 31, 2014 - InvestorPlace.com
Jim Cramer's 'Mad Money' Recap: How to Become an Even Better Investor 7:00 p.m. Dec. 30, 2014 - TheStreet.com
Portfolio Changes For The Fourth Quarter Of 2014 1:35 p.m. Dec. 30, 2014 - Seeking Alpha
InsiderInsights.com Daily Round Up 12/29/14: REGN, VRML, OAS, PTBI 1:23 p.m. Dec. 30, 2014 - Seeking Alpha
Esperion Therapeutics: ETC-1002 Is Appealing, But The Valuation Is Not 7:22 a.m. Dec. 30, 2014 - Seeking Alpha
DoctoRx Positions For 2015: I Have Cut Back On My Exposure To All Biotech Substantially 7:05 a.m. Dec. 30, 2014 - Seeking Alpha
Stock Market News for December 26, 2014 - Market News 10:10 a.m. Dec. 26, 2014 - Zacks.com
Why I Expect The Biotech Sell-Off To Continue Into 2015 8:08 a.m. Dec. 24, 2014 - Seeking Alpha
Regeneron's Valuation Has Moved Ahead Of Its Growth Potential 7:27 a.m. Dec. 24, 2014 - Seeking Alpha
Dow Reaches Record Close as Santa Claus Rally Hits Day 5 4:04 p.m. Dec. 23, 2014 - TheStreet.com
Dow, S&P 500 Near Session Highs After GDP Growth Smashes Expectations 2:25 p.m. Dec. 23, 2014 - TheStreet.com
Dow Industrials Top 18,000 but Biopharma Stocks Drag Nasdaq Lower 11:29 a.m. Dec. 23, 2014 - TheStreet.com
RBC’s 5 Top Biotech Stocks to Buy for 2015 9:07 a.m. Dec. 23, 2014 - 247WallSt.com
Making Money With Charles Payne: 12/22/14 6:00 p.m. Dec. 22, 2014 - FOXBusiness
Jim Cramer Answers Twitter (TWTR) Questions on Gilead, WhiteWave Foods, and More 1:37 p.m. Dec. 22, 2014 - TheStreet.com
Trade of the Day: IBB Up 40% YTD – Buy, Sell or Hold? 7:17 p.m. Dec. 21, 2014 - InvestorPlace.com
Seeking Alpha's Biotech Weekly: A Merck Purchase, Spectacular Auspex, And More 4:00 p.m. Dec. 19, 2014 - Seeking Alpha
Critical Alerts For iRobot, Regeneron Pharmaceuticals, Sears Holdings, Starbucks and Goldcorp Released By InvestorsObserver 9:31 a.m. Jan. 2, 2015 - PR Newswire - PRF
Regeneron Announces Presentation and Panel Discussion at the 33rd Annual J.P. Morgan Healthcare Conference 9:30 a.m. Dec. 19, 2014 - PR Newswire - PRF
Have You Been Counted? Regeneron and Sanofi US Join Forces with Leading Cardiovascular Organizations to Raise Awareness of Cholesterol 8:00 a.m. Dec. 15, 2014 - PR Newswire - PRF
Ablexis Announces Availability of the AlivaMab Mouse Technology and Settlement of the Litigation with Regeneron Pharmaceuticals, Inc. 8:01 a.m. Dec. 4, 2014 - BusinessWire - BZX
EYLEA® (aflibercept) Injection Accepted for Priority Review by FDA for Diabetic Retinopathy in Patients with Diabetic Macular Edema 7:00 a.m. Dec. 1, 2014 - PR Newswire - PRF
Critical Alerts For Qihoo 360 Technology, Regeneron Pharmaceuticals, Autodesk, Akamai Technologies and General Motors Released By InvestorsObserver 9:31 a.m. Nov. 26, 2014 - PR Newswire - PRF
Biotech Stocks in Motion - Amgen, Merrimack Pharma, NPS Pharma, BioMarin Pharma, and Regeneron Pharma 8:45 a.m. Nov. 24, 2014 - PR Newswire - PRF
Regeneron and Sanofi Announce that Dupilumab Has Received FDA Breakthrough Therapy Designation in Atopic Dermatitis 1:30 a.m. Nov. 20, 2014 - PR Newswire - PRF
Regeneron and Sanofi Announce New Results from Six Phase 3 Trials Showing that Alirocumab Significantly Reduced LDL Cholesterol 8:15 a.m. Nov. 19, 2014 - PR Newswire - PRF
Regeneron Announces EYLEA® (aflibercept) Injection Approved for the Treatment of Diabetic Macular Edema (DME) in Japan 3:05 a.m. Nov. 18, 2014 - PR Newswire - PRF
Regeneron and Sanofi Announce Positive Results from Phase 2b Study of Dupilumab in Patients with Moderate-to-Severe Asthma 1:00 a.m. Nov. 11, 2014 - PR Newswire - PRF
Regeneron Reports Third Quarter 2014 Financial and Operating Results 6:30 a.m. Nov. 4, 2014 - PR Newswire - PRF
Regeneron Announces Upcoming 2014 Investor Conference Presentations 4:01 p.m. Nov. 3, 2014 - PR Newswire - PRF
Upcoming Earnings, Financial Results, New Affiliations, and Study Results - Research Reports on Regeneron, Valeant, CVS Health, CIGNA and Baxter 9:15 a.m. Nov. 3, 2014 - PR Newswire - PRF
New Solution for Patients, Quarterly Financial Results, Clinical Study Initiation, Merger Updates, and Product Launch - Research Reports on CVS, Valeant, Regeneron, Allergan and Agilent 9:20 a.m. Oct. 23, 2014 - PR Newswire - PRF
Analyst Scanner on Biotech Equities - Amgen, Exelixis, Regeneron Pharma, Lexicon Pharma, and BioMarin Pharma 9:00 a.m. Oct. 20, 2014 - PR Newswire - PRF
Regeneron and Sanofi Announce Start of Phase 3 Study of Dupilumab in Patients with Atopic Dermatitis 7:00 a.m. Oct. 20, 2014 - PR Newswire - PRF
EYLEA® (aflibercept) Injection Demonstrates Significantly Greater Gains in Visual Acuity than Both Bevacizumab and Ranibizumab in NIH-Sponsored Diabetic Macular Edema Study 7:00 a.m. Oct. 17, 2014 - PR Newswire - PRF
Regeneron Ranked Number One Biopharmaceutical Employer by Science Magazine for Third Consecutive Year 2:00 p.m. Oct. 16, 2014 - PR Newswire - PRF
Regeneron Genetics Center Fully Operational, Announces New Collaborations and Key Appointments 8:30 a.m. Oct. 16, 2014 - PR Newswire - PRF
(0)
(0)